Wörwag Pharma GmbH & Co. KG
Dr. Carola Schneider is a Project Manager in Product Development at Wörwag Pharma GmbH & Co. KG since August 2017 and has also served as a Clinical Research Associate at iOMEDICO since January 2016, focusing on clinical study management, regulatory affairs, ICH-GCP compliance, and monitoring. Between 2012 and 2015, Dr. Schneider was a doctoral candidate at the Hertie-Institute for Clinical Brain Research, conducting research on the implications of spastic paraplegia related to Kinesin-1 function in a Drosophila model. Dr. Schneider's education includes a degree in Quality Management/Project Management from WBS Training in 2015, a diploma in Biology from the University of Hohenheim (2006-2011), and a research degree from the Instituto de Pesquisas Energéticas e Nucleares in Brazil (2010-2011).
This person is not in any offices
Wörwag Pharma GmbH & Co. KG
Woerwag Pharma GmbH & Co. KG is a family-owned and international operating pharmaceutical company headquartered in Boeblingen, Germany, developing and selling biofactor preparations wordwide with more than 1400 employees in 35 countries. The company’s product rage is exclusively available in pharmacies and includes both prescription preparations as well as over the counter (OTC) products and food supplements. Therapeutic areas focus on diabetic comorbidities, diseases of the nervous system, of the musculoskeletal system, as well as on stabilizing the immune system.